Design Therapeutics Inc (DSGN) — Financial Flexibility Index
Design Therapeutics Inc (DSGN) has a Financial Flexibility Index of -0.93x as of September 2025. Free cash flow of $-11.16 Million (operating CF $-11.16 Million minus capex $0.00) represents -1% of total liabilities ($12.05 Million). Check how strategically is Design Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Design Therapeutics Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Design Therapeutics Inc across 6 annual periods. See DSGN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Design Therapeutics Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Design Therapeutics Inc. For the full company profile including market capitalisation, see DSGN company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.28x | $-42.77 Million | $-43.10 Million | $10.00 Million | ▲ +12.3% |
| 2023 | -4.88x | $-58.30 Million | $-58.56 Million | $11.96 Million | ▼ -33.8% |
| 2022 | -3.64x | $-50.40 Million | $-51.32 Million | $13.83 Million | ▼ -10.3% |
| 2021 | -3.30x | $-27.84 Million | $-29.38 Million | $8.43 Million | ▼ -1738.8% |
| 2020 | -0.18x | $-8.59 Million | $-8.67 Million | $47.83 Million | ▼ -964.2% |
| 2019 | -0.02x | $-63.00K | $-139.00K | $3.73 Million | — |